Transdermal Therapeutic Systems for the Treatment of Alzheimer's Disease: A Patent Review.

Letícia BassoSilvia Cristina FagundesTatiana StaudtKarini da RosaElizane LangaroHossein Omidian Charise Dallazem Bertol

Published in: CNS & neurological disorders drug targets (2023)

TTSs are primarily effective for delivering small molecules. The use of absorption enhancers and irritation mitigators can be necessary to enhance the performance. The development of these technologies is essential for the convenience of patients and caregivers.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
patient reported outcomes
mild cognitive impairment
patient reported